{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:14:12Z","timestamp":1790151252663,"version":"4.0.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,10,7]],"date-time":"2017-10-07T00:00:00Z","timestamp":1507334400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s11882-017-0748-4","type":"journal-article","created":{"date-parts":[[2017,10,7]],"date-time":"2017-10-07T06:25:30Z","timestamp":1507357530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Mastocytosis in Children"],"prefix":"10.1007","volume":"17","author":[{"given":"Nicholas","family":"Klaiber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santhosh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Irani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,7]]},"reference":[{"key":"748_CR1","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/jid.2009.291","volume":"130","author":"N Kambe","year":"2010","unstructured":"Kambe N, Longley BJ, Miyachi Y, Kabashima K. KIT masters mast cells in kids, too. J Invest Dermatol. 2010;130:648\u201350.","journal-title":"J Invest Dermatol"},{"key":"748_CR2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.iac.2014.01.003","volume":"34","author":"K Brockow","year":"2014","unstructured":"Brockow K. Epidemiology, prognosis, and risk factors in mastocytosis. Immunol Allergy Clin N Am. 2014;34:283\u201395.","journal-title":"Immunol Allergy Clin N Am"},{"key":"748_CR3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/ped.2013.0275","volume":"26","author":"M Frieri","year":"2013","unstructured":"Frieri M, Quershi M. Pediatric mastocytosis: a review of the literature. Pediatr Allergy Immunol Pulmonol. 2013;26:175\u201380.","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"key":"748_CR4","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1525-1470.2011.01650.x","volume":"29","author":"R Chantorn","year":"2012","unstructured":"Chantorn R, Shwayder T. Death from mast cell leukemia: a young patient with longstanding cutaneous mastocytosis evolving into fatal mast cell leukemia. Pediatr Dermatol. 2012;29:605\u20139.","journal-title":"Pediatr Dermatol"},{"key":"748_CR5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/pbc.22125","volume":"53","author":"A Uzzaman","year":"2009","unstructured":"Uzzaman A, et al. Pediatric-onset mastocytosis: a long term clinical follow-up and correlation with bone marrow histopathology. Pediatr Blood Cancer. 2009;53:629\u201334.","journal-title":"Pediatr Blood Cancer"},{"key":"748_CR6","doi-asserted-by":"publisher","unstructured":"Huang A, Fiadorchanka N, Brar K, Balderacchi JL, Glick SA. In-utero presentation of aggressive systemic mastocytosis in a neonate. Br J Dermatol 2017; https:\/\/doi.org\/10.1111\/bjd.15506 .","DOI":"10.1111\/bjd.15506"},{"key":"748_CR7","doi-asserted-by":"crossref","first-page":"e1906","DOI":"10.1371\/journal.pone.0001906","volume":"3","author":"F Lanternier","year":"2008","unstructured":"Lanternier F, et al. Phenotypic and genotypic characteristics of mastocytosis according to the age of onset. PLoS One. 2008;3:e1906.","journal-title":"PLoS One"},{"key":"748_CR8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s11882-013-0392-6","volume":"13","author":"AJ Fried","year":"2013","unstructured":"Fried AJ, Akin C. Primary mast cell disorders in children. Curr Allergy Asthma Rep. 2013;13:693\u2013701.","journal-title":"Curr Allergy Asthma Rep"},{"key":"748_CR9","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Hartmann K, et al. Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology. J Allergy Clin Immunol. 2016;137:35\u201345. This report describes the current classification of cutaneous mastocytosis and reviews prognostic considerations.","DOI":"10.1016\/j.jaci.2015.08.034"},{"key":"748_CR10","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jaci.2015.05.034","volume":"136","author":"T Wiechers","year":"2015","unstructured":"Wiechers T, et al. Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis. J Allergy Clin Immunol. 2015;136:1581\u20131590.e3.","journal-title":"J Allergy Clin Immunol"},{"key":"748_CR11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s40521-016-0103-3","volume":"3","author":"MC Onnes","year":"2016","unstructured":"Onnes MC, Tanno LK, Elberink JN. Mast cell clonal disorders: classification, diagnosis and management. Curr Treat Options Allergy. 2016;3:453\u201364.","journal-title":"Curr Treat Options Allergy"},{"key":"748_CR12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/pde.13040","volume":"34","author":"T Piqueres-Zubiaurre","year":"2017","unstructured":"Piqueres-Zubiaurre T, Martinez de Lagran Z, Gonzalez-Perez R, Urtaran-Ibarzabal A, Perez de Nanclares G. Familial progressive hyperpigmentation, cutaneous mastocytosis, and gastrointestinal stromal tumor as clinical manifestations of mutations in the c-KIT receptor gene. Pediatr Dermatol. 2017;34:84\u20139.","journal-title":"Pediatr Dermatol"},{"key":"748_CR13","first-page":"320","volume":"7","author":"D Ben-Amitai","year":"2005","unstructured":"Ben-Amitai D, Metzker A, Cohen HA. Pediatric cutaneous mastocytosis: a review of 180 patients. Isr Med Assoc J. 2005;7:320\u20132.","journal-title":"Isr Med Assoc J"},{"key":"748_CR14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11882-012-0322-z","volume":"13","author":"M Frieri","year":"2013","unstructured":"Frieri M, Patel R, Celestin J. Mast cell activation syndrome: a review. Curr Allergy Asthma Rep. 2013;13:27\u201332.","journal-title":"Curr Allergy Asthma Rep"},{"key":"748_CR15","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1182\/blood.V80.9.2237.2237","volume":"80","author":"P Valent","year":"1992","unstructured":"Valent P, et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor\/kit-ligand in long-term culture. Blood. 1992;80:2237\u201345.","journal-title":"Blood"},{"key":"748_CR16","doi-asserted-by":"publisher","unstructured":"Kristensen T, Vestergaard H, Bindslev-Jensen C, Mortz CG, Kjaer HF, Ollert M, et al. Prospective evaluation of the diagnostic value of sensitive KIT D816V mutation analysis of blood in adults with suspected systemic mastocytosis. Allergy 2017; https:\/\/doi.org\/10.1111\/all.13187 .","DOI":"10.1111\/all.13187"},{"key":"748_CR17","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/jid.2009.281","volume":"130","author":"C Bodemer","year":"2010","unstructured":"Bodemer C, et al. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. J Invest Dermatol. 2010;130:804\u201315.","journal-title":"J Invest Dermatol"},{"key":"748_CR18","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","volume":"96","author":"BJ Longley Jr","year":"1999","unstructured":"Longley BJ Jr, et al. Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci U S A. 1999;96:1609\u201314.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"748_CR19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13578-016-0120-8","volume":"6","author":"H Ke","year":"2016","unstructured":"Ke H, Kazi JU, Zhao H, Sun J. Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis. Cell Biosci. 2016;6:55.","journal-title":"Cell Biosci"},{"key":"748_CR20","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.0303-6987.2004.00182.x","volume":"31","author":"TC Brauns","year":"2004","unstructured":"Brauns TC, Schultewolter T, Dissemond J, Maschke J, Goos M. C-KIT expression in primary cutaneous T-cell lymphomas. J Cutan Pathol. 2004;31:577\u201382.","journal-title":"J Cutan Pathol"},{"key":"748_CR21","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3324\/haematol.2017.163964","volume":"102","author":"M Jawhar","year":"2017","unstructured":"Jawhar M, et al. The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasm. Haematologica. 2017;102:1035\u201343.","journal-title":"Haematologica"},{"key":"748_CR22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/MPH.0b013e318063ef26","volume":"29","author":"JW Lee","year":"2007","unstructured":"Lee JW, et al. Aggressive systemic mastocytosis after germ cell tumor of the ovary: C-KIT mutation documentation in both disease states. J Pediatr Hematol Oncol. 2007;29:412\u20135.","journal-title":"J Pediatr Hematol Oncol"},{"key":"748_CR23","doi-asserted-by":"crossref","first-page":"e97519","DOI":"10.1371\/journal.pone.0097519","volume":"9","author":"P Figueiredo Celestino Gomes Da Silva","year":"2014","unstructured":"Da Silva Figueiredo Celestino Gomes P, et al. Differential effects of CSF-1R D802V and KIT D816V homologous mutations on receptor tertiary structure and allosteric communication. PLoS One. 2014;9:e97519.","journal-title":"PLoS One"},{"key":"748_CR24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fmed.2017.00110","volume":"4","author":"M Vaes","year":"2017","unstructured":"Vaes M, Benghiat FS, Hermine O. Targeted treatment options in mastocytosis. Front Med (Lausanne). 2017;4:110.","journal-title":"Front Med (Lausanne)"},{"key":"748_CR25","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1056\/NEJMoa1513098","volume":"374","author":"J Gotlib","year":"2016","unstructured":"Gotlib J, et al. Efficacy and safety of midostaurin in advanced systemic mastocytosis. N Engl J Med. 2016;374:2530\u201341.","journal-title":"N Engl J Med"},{"key":"748_CR26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.tins.2013.06.001","volume":"36","author":"R Silver","year":"2013","unstructured":"Silver R, Curley JP. Mast cells on the mind: new insights and opportunities. Trends Neurosci. 2013;36:513\u201321.","journal-title":"Trends Neurosci"},{"key":"748_CR27","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Carter MC, et al. Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis. J Allergy Clin Immunol. 2015;136:1673\u20131679.e3. This report clarifies the clinical value of serum tryptase levels and bone marrow biopsy on management considerations.","DOI":"10.1016\/j.jaci.2015.04.024"},{"key":"748_CR28","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1053\/j.gastro.2005.06.060","volume":"129","author":"K Hartmann","year":"2005","unstructured":"Hartmann K, et al. Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis. Gastroenterology. 2005;129:1042\u20136.","journal-title":"Gastroenterology"},{"key":"748_CR29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/ced.12225","volume":"39","author":"HJ Wang","year":"2014","unstructured":"Wang HJ, Lin ZM, Zhang J, Yin JH, Yang Y. A new germline mutation in KIT associated with diffuse cutaneous mastocytosis in a Chinese family. Clin Exp Dermatol. 2014;39:146\u20139.","journal-title":"Clin Exp Dermatol"},{"key":"748_CR30","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1136\/jmg.2003.015156","volume":"41","author":"X Tang","year":"2004","unstructured":"Tang X, et al. A germline mutation in KIT in familial diffuse cutaneous mastocytosis. J Med Genet. 2004;41:e88.","journal-title":"J Med Genet"},{"key":"748_CR31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","volume":"25","author":"P Valent","year":"2001","unstructured":"Valent P, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001;25:603\u201325.","journal-title":"Leuk Res"},{"key":"748_CR32","doi-asserted-by":"crossref","unstructured":"\u2022 Akin C. Mast cell activation syndromes. J Allergy Clin Immunol. 2017;140:349\u201355. This report describes the clinical features and diagnostic criteria of mast cell activation syndrome.","DOI":"10.1016\/j.jaci.2017.06.007"},{"key":"748_CR33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.iac.2014.02.003","volume":"34","author":"C Akin","year":"2014","unstructured":"Akin C, Valent P. Diagnostic criteria and classification of mastocytosis in 2014. Immunol Allergy Clin N Am. 2014;34:207\u201318.","journal-title":"Immunol Allergy Clin N Am"},{"key":"748_CR34","doi-asserted-by":"crossref","unstructured":"\u2022 Lyons JJ, et al. Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number. Nat Genet. 2016;48:1564\u20139. This is the first report of a genetic condition with multisystem organ involvement and elevated basal serum tryptase level.","DOI":"10.1038\/ng.3696"},{"key":"748_CR35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0190-9622(95)90336-4","volume":"32","author":"J Longley","year":"1995","unstructured":"Longley J, Duffy TP, Kohn S. The mast cell and mast cell disease. J Am Acad Dermatol. 1995;32:545\u2013561; quiz 562-4.","journal-title":"J Am Acad Dermatol"},{"key":"748_CR36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1398-9995.2012.02812.x","volume":"67","author":"I Alvarez-Twose","year":"2012","unstructured":"Alvarez-Twose I, et al. Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis. Allergy. 2012;67:813\u201321.","journal-title":"Allergy"},{"key":"748_CR37","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000329856","volume":"157","author":"I Alvarez-Twose","year":"2012","unstructured":"Alvarez-Twose I, et al. Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms. Int Arch Allergy Immunol. 2012;157:275\u201380.","journal-title":"Int Arch Allergy Immunol"},{"key":"748_CR38","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S1081-1206(10)63145-6","volume":"81","author":"C Moore","year":"1998","unstructured":"Moore C, Ehlayel MS, Junprasert J, Sorensen RU. Topical sodium cromoglycate in the treatment of moderate-to-severe atopic dermatitis. Ann Allergy Asthma Immunol. 1998;81:452\u20138.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"748_CR39","doi-asserted-by":"publisher","unstructured":"Edwards AM, Capkova S. Oral and topical sodium cromoglicate in the treatment of diffuse cutaneous mastocytosis in an infant. BMJ Case Rep. 2011; https:\/\/doi.org\/10.1136\/bcr.02.2011.3910 (2011) .","DOI":"10.1136\/bcr.02.2011.3910%20(2011)"},{"key":"748_CR40","first-page":"CD008838","volume":"10","author":"RJ Boyle","year":"2012","unstructured":"Boyle RJ, et al. Venom immunotherapy for preventing allergic reactions to insect stings. Cochrane Database Syst Rev. 2012;10:CD008838.","journal-title":"Cochrane Database Syst Rev"},{"key":"748_CR41","doi-asserted-by":"crossref","unstructured":"\u2022 Matito A, et al. Management of anesthesia in adult and pediatric mastocytosis: a study of the Spanish Network on Mastocytosis (REMA) based on 726 anesthetic procedures. Int Arch Allergy Immunol. 2015;167:47\u201356. This report clarifies the use of anesthetic agents with a decreased risk of triggering mast cell activation events in patients with mastocytosis.","DOI":"10.1159\/000436969"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-017-0748-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-017-0748-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-017-0748-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T22:11:30Z","timestamp":1603059090000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-017-0748-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,7]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["748"],"URL":"https:\/\/doi.org\/10.1007\/s11882-017-0748-4","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,7]]},"article-number":"80"}}